Skip to main content

Advertisement

Log in

Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features

  • Review Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

The classification of vascular bone tumors remains challenging, with considerable morphological overlap spanning across benign to malignant categories. The vast majority of both benign and malignant vascular tumors are readily diagnosed based on their characteristic histological features, such as the formation of vascular spaces and the expression of endothelial markers. However, some vascular tumors have atypical histological features, such as a solid growth pattern, epithelioid change, or spindle cell morphology, which complicates their diagnosis. Pathologically, these tumors are remarkably similar, which makes differentiating them from each other very difficult. For this rare subset of vascular bone tumors, there remains considerable controversy with regard to the terminology and the classification that should be used. Moreover, one of the most confusing issues related to vascular bone tumors is the myriad of names that are used to describe them. Because the clinical behavior and, consequently, treatment and prognosis of vascular bone tumors can vary significantly, it is important to effectively and accurately distinguish them from each other. Upon review of the nomenclature and the characteristic clinicopathological, radiographic and genetic features of vascular bone tumors, we propose a classification scheme that includes hemangioma, hemangioendothelioma, angiosarcoma, and their epithelioid variants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Folpe AL, Chand EM, Goldblum JR, Weiss SW. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol. 2001;25(8):1061–6.

    Article  PubMed  CAS  Google Scholar 

  2. O’Connell JX, Nielsen GP, Rosenberg AE. Epithelioid vascular tumors of bone: a review and proposal of a classification scheme. Adv Anat Pathol. 2001;8(2):74–82.

    Article  PubMed  Google Scholar 

  3. Evans HL, Raymond AK, Ayala AG. Vascular tumors of bone: a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma. Hum Pathol. 2003;34(7):680–9.

    Article  PubMed  Google Scholar 

  4. World Health Organization Classification of Tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002.

    Google Scholar 

  5. Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki RG, Healey JH, Antonescu CR. A novel WWTR1-CAMTA1 gene fusion is consistent abnormality in epithelioid hemangioendotelioma of different anatomic sites. Gene Chromosome Cancer. 2011;50(8):644–53. doi:10.1002/gcc.20886

    Article  CAS  Google Scholar 

  6. Deyrup AT, Montag AG. Epithelioid and epithelial neoplasm of bone. Arch Pathol Lab Med. 2007;131(2):205–16.

    PubMed  Google Scholar 

  7. Wenger DE, Wold LE. Benign vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol. 2000;29(2):63–74.

    Article  PubMed  CAS  Google Scholar 

  8. Campanacci M. Bone and soft tissue tumors. 2nd ed. New York: Springer; 1999.

    Google Scholar 

  9. Kaleem Z, Kyriakos M, Totty WG. Solitary skeletal hemangioma of the extremities. Skeletal Radiol. 2000;29(9):502–13.

    Article  PubMed  CAS  Google Scholar 

  10. Italiano A, Thomas R, Breen M, Zhang L, Crago AM, Singer S, Khanin R, Maki RG, Mihailovic A, Hafner M, Tuschl T, Antonescu CR. The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification. Genes Chromosomes Cancer. 2012;51(6):569–78.

    Article  PubMed  CAS  Google Scholar 

  11. Calicchio ML, Collins T, Kozakewich HP. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling. Am J Pathol. 2009;174(5):1638–49.

    Article  PubMed  CAS  Google Scholar 

  12. Wu JK, Adepoju O, De Silva D, Baribault K, Boscolo E, Bischoff J, Kitajewski J. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis. 2010;13(1):15–23.

    Article  PubMed  CAS  Google Scholar 

  13. Adepoju O, Wong A, Kitajewski A, Tong K, Boscolo E, Bischoff J, Kitajewski J, Wu JK. Expression of HES and HEY genes in infantile hemangiomas. Vasc Cell. 2011;3:19.

    Article  PubMed  CAS  Google Scholar 

  14. Mihm Jr MC, Nelson JS. Hypothesis: the metastatic niche theory can elucidate infantile hemangioma development. J Cutan Pathol. 2010;37 [Suppl 1]:83–7.

    Article  PubMed  Google Scholar 

  15. North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, Suen JY, Mihm Jr MC. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001;137(5):559–70.

    PubMed  CAS  Google Scholar 

  16. Barnés CM, Huang S, Kaipainen A, Sanoudou D, Chen EJ, Eichler GS, Guo Y, Yu Y, Ingber DE, Mulliken JB, Beggs AH, Folkman J, Fishman SJ. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci U S A. 2005;102(52):19097–102.

    Article  PubMed  Google Scholar 

  17. Errani C, Sung YS, Zhang L, Healey JH, Antonescu CR. Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints. Cancer Genet. 2012;205(1–2):12–7.

    Article  PubMed  CAS  Google Scholar 

  18. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820–7.

    Article  PubMed  CAS  Google Scholar 

  19. Blecher R, Smorgick Y, Anekstein Y, Peer A, Mirovsky Y. Management of symptomatic vertebral hemangioma: follow-up of 6 patients. J Spinal Disord Tech. 2001;24(3):196–201.

    Article  Google Scholar 

  20. Nielsen GP, Srivastava A, Kattapuram S, Deshpande V, O’Connell JX, Mangham CD, Rosenberg AE. Epithelioid hemangioma of bone revisited: a study of 50 cases. Am J Surg Pathol. 2009;33(2):270–7.

    Article  PubMed  Google Scholar 

  21. Sung MS, Kim YS, Resnick D. Epithelioid hemangioma of bone. Skeletal Radiol. 2000;29(9):530–4.

    Article  PubMed  CAS  Google Scholar 

  22. Floris G, Deraedt K, Samson I, Brys P, Sciot R. Epithelioid hemangioma of bone: a potentially metastasizing tumor? Int J Surg Pathol. 2006;14(1):9–15. discussion 16–20.

    Article  PubMed  Google Scholar 

  23. Gupta A, Saifuddin A, Briggs TW, Flanagan AM. Subperiosteal hemangioendothelioma of the femur. Skeletal Radiol. 2006;35(10):793–6.

    Article  PubMed  Google Scholar 

  24. Shah ZK, Peh WC, Shek TW, Wong JW, Chien EP. Hemangioendothelioma with an epithelioid phenotype arising in hemangioma of the fibula. Skeletal Radiol. 2005;34(11):750–4.

    Article  PubMed  Google Scholar 

  25. O’Connell JX, Kattapuram SV, Mankin HJ, Bhan AK, Rosenberg AE. Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol. 1993;17(6):610–7.

    Article  PubMed  Google Scholar 

  26. Errani C, Zhang L, Panicek DM, Healey JH, Antonescu CR. Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity. Clin Orthop Relat Res. 2012;470(5):1498–506.

    Article  PubMed  Google Scholar 

  27. Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M. Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev. 2010;36(1):1–7.

    Article  PubMed  Google Scholar 

  28. Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011;469(2):591–9.

    Article  PubMed  Google Scholar 

  29. Wenger DE, Wold LE. Malignant vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol. 2000;29(11):619–31.

    Article  PubMed  CAS  Google Scholar 

  30. Bovée JV, Hogendoorn PC. Molecular pathology of sarcomas: concepts and clinical implications. Virchows Arch. 2010;456(2):193–9.

    Article  PubMed  Google Scholar 

  31. Murali R, Zarka MA, Ocal IT, Tazelaar HD. Cytologic features of epithelioid hemangioendothelioma. Am J Clin Pathol. 2011;136(5):739–46.

    Article  PubMed  Google Scholar 

  32. Antonescu CR, Elahi A, Healey JH, Brennan MF, Lui MY, Lewis J, Jhanwar SC, Woodruff JM, Ladanyi M. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin Cancer Res. 2000;6(7):2788–93.

    PubMed  CAS  Google Scholar 

  33. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res. 2005;11(3):1119–28.

    PubMed  CAS  Google Scholar 

  34. Henrich KO, Fischer M, Mertens D, Benner A, Wiedemeyer R, Brors B, Oberthuer A, Berthold F, Wei JS, Khan J, Schwab M, Westermann F. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res. 2006;12(1):131–8.

    Article  PubMed  CAS  Google Scholar 

  35. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Y, Guan KL. TAZ promotes cell proliferation and epithelial–mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol. 2008;28(7):2426–36.

    Article  PubMed  CAS  Google Scholar 

  36. Chan SW, Lim CJ, Loo LS, Chong YF, Huang C, Hong W. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J Biol Chem. 2009;284(21):14347–58.

    Article  PubMed  CAS  Google Scholar 

  37. Zhang H, Liu CY, Zha ZY, Zhao B, Yao J, Zhao S, Xiong Y, Lei QY, Guan KL. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial–mesenchymal transition. J Biol Chem. 2009;284(20):13355–62.

    Article  PubMed  CAS  Google Scholar 

  38. Lau K, Massad M, Pollak C, Rubin C, Yeh J, Wang J, Edelman G, Yeh J, Prasad S, Weinberg G. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer. Chest. 2011;140(5):1312–8.

    Article  PubMed  Google Scholar 

  39. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8(2):98–101.

    PubMed  CAS  Google Scholar 

  40. Kaplan RN, Rafii S, Lyden D. Preparing the “soil”: the premetastatic niche. Cancer Res. 2006;66(23):11089–93.

    Article  PubMed  CAS  Google Scholar 

  41. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–95.

    Article  PubMed  CAS  Google Scholar 

  42. Norton L, Massagué J. Is cancer a disease of self-seeding? Nat Med. 2006;12(8):875–8.

    Article  PubMed  CAS  Google Scholar 

  43. Larochelle O, Périgny M, Lagacé R, Dion N, Giguère C. Best cases from the AFIP: epithelioid hemangioendothelioma of bone. Radiographics. 2006;26(1):265–70.

    Article  PubMed  Google Scholar 

  44. Gill R, O’Donnell RJ, Horvai A. Utility of immunohistochemistry for endothelial markers in distinguishing epithelioid hemangioendothelioma from carcinoma metastatic to bone. Arch Pathol Lab Med. 2009;133(6):967–72.

    PubMed  CAS  Google Scholar 

  45. Lewis CJ, Gerrand C, Barnes DE, Murray S, Milner RH, Ragbir M. Experience of angiosarcoma in the North of England Bone and Soft Tissue Tumour Service. J Plast Reconstr Aesthet Surg. 2011;64(7):884–91.

    Article  PubMed  CAS  Google Scholar 

  46. Deshpande V, Rosenberg AE, O’Connell JX, Nielsen GP. Epithelioid angiosarcoma of the bone: a series of 10 cases. Am J Surg Pathol. 2003;27(6):709–16.

    Article  PubMed  Google Scholar 

  47. Hart J, Mandavilli S. Epithelioid angiosarcoma: a brief diagnostic review and differential diagnosis. Arch Pathol Lab Med. 2011;135(2):268–72.

    PubMed  Google Scholar 

  48. Kleer CG, Unni KK, McLeod RA. Epithelioid hemangioendothelioma of bone. Am J Surg Pathol. 1996;20(11):1301–11.

    Article  PubMed  CAS  Google Scholar 

  49. Cao Y, Zou SM, Zhang KT, Lu N, Liu Y, Feng L, Wen P, Han NJ, Lin DM. Genetic alterations in pulmonary epithelioid hemangioendothelioma and epithelioid angiosarcoma. Histol Histopathol. 2011;26(4):491–6.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Costantino Errani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Errani, C., Vanel, D., Gambarotti, M. et al. Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features. Skeletal Radiol 41, 1495–1507 (2012). https://doi.org/10.1007/s00256-012-1510-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-012-1510-6

Keywords

Navigation